感染后肠易激综合征证候及病理机制研究思路探讨

秦书敏, 杨元明, 吴皓萌, 等. 感染后肠易激综合征证候及病理机制研究思路探讨[J]. 中国中西医结合消化杂志, 2023, 31(1): 61-64. doi: 10.3969/j.issn.1671-038X.2023.01.11
引用本文: 秦书敏, 杨元明, 吴皓萌, 等. 感染后肠易激综合征证候及病理机制研究思路探讨[J]. 中国中西医结合消化杂志, 2023, 31(1): 61-64. doi: 10.3969/j.issn.1671-038X.2023.01.11
QIN Shumin, YANG Yuanming, WU Haomeng, et al. Discussion on the research idea of the syndromes and pathological mechanism of post-infectious irritable bowel syndrome[J]. Chin J Integr Tradit West Med Dig, 2023, 31(1): 61-64. doi: 10.3969/j.issn.1671-038X.2023.01.11
Citation: QIN Shumin, YANG Yuanming, WU Haomeng, et al. Discussion on the research idea of the syndromes and pathological mechanism of post-infectious irritable bowel syndrome[J]. Chin J Integr Tradit West Med Dig, 2023, 31(1): 61-64. doi: 10.3969/j.issn.1671-038X.2023.01.11

感染后肠易激综合征证候及病理机制研究思路探讨

  • 基金项目:
    国家自然科学基金(No:81904148,No:81703992,No:81974563);中国博士后科学基金项目(No:2018M640222);北京市自然科学基金资助项目(No:7192184);广东省普通高校青年创新人才项目(No:2019KQNCX023);广东省医学科学技术研究基金项目(No:A2020181,No:A2017394);广东省中医药局中医药科研项目(No:20192024);广州市科技计划项目(No:20210201040527);广东省中医院中医药科学技术研究专项(No:YN2016QJ14)
详细信息

Discussion on the research idea of the syndromes and pathological mechanism of post-infectious irritable bowel syndrome

More Information
  • 感染后肠易激综合征是肠易激综合征的一种类型,即以前无IBS症状的人群在感染性胃肠炎发作后随即发生的肠易激综合征。肠道免疫活化、持续低度炎症和内脏高敏感是感染后肠易激综合征主要的病理特征;而在肝郁脾虚的基础上存在邪气未尽、伏藏于内的正邪交争状态是其中医病机特点,其中湿邪是导致其反复发作,难以速去的关键。该文从肠道免疫活化介导内脏高敏感的角度探讨其核心病机肝郁脾虚夹湿证病理机制的研究思路,以期为后续的进一步深入研究提供参考。
  • 加载中
  • [1]

    Barbara G, Grover M, Bercik P, et al. Rome Foundation Working Team Report on Post-Infection Irritable Bowel Syndrome[J]. Gastroenterology, 2019, 156(1): 46-58. doi: 10.1053/j.gastro.2018.07.011

    [2]

    Card T, Enck P, Barbara G, et al. Post-infectious IBS: Defining its clinical features and prognosis using an internet-based survey[J]. United European Gastroenterol J, 2018, 6(8): 1245-1253. doi: 10.1177/2050640618779923

    [3]

    Scallan WE, Crim SM, Bruce BB, et al. Postinfectious Irritable Bowel Syndrome After Campylobacter Infection[J]. Am J Gastroenterol, 2019, 114(10): 1649-1656. doi: 10.14309/ajg.0000000000000408

    [4]

    Berumen A, Lennon R, Breen-Lyles M, et al. Characteristics and Risk Factors of Post-Infection Irritable Bowel Syndrome After Campylobacter Enteritis[J]. Clin Gastroenterol Hepatol, 2021, 19(9): 1855-1863. doi: 10.1016/j.cgh.2020.07.033

    [5]

    张声生, 魏玮, 杨俭勤. 肠易激综合征中医诊疗专家共识意见(2017)[J]. 中医杂志, 2017, 58(18): 1614-1620. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ201718024.htm

    [6]

    Du L, Long Y, Kim JJ, et al. Protease Activated Receptor-2 Induces Immune Activation and Visceral Hypersensitivity in Post-infectious Irritable Bowel Syndrome Mice[J]. Dig Dis Sci, 2019, 64(3): 729-739. doi: 10.1007/s10620-018-5367-y

    [7]

    Ghoshal UC. Postinfection Irritable Bowel Syndrome[J]. Gut Liver, 2022, 16(3): 331-340. doi: 10.5009/gnl210208

    [8]

    Pike BL, Paden KA, Alcala AN, et al. Immunological Biomarkers in Postinfectious Irritable Bowel Syndrome[J]. J Travel Med, 2015, 22(4): 242-250. doi: 10.1111/jtm.12218

    [9]

    Sundin J, Rangel I, Kumawat AK, et al. Aberrant mucosal lymphocyte number and subsets in the colon of post-infectious irritable bowel syndrome patients[J]. Scand J Gastroenterol, 2014, 49(9): 1068-1075. doi: 10.3109/00365521.2014.926982

    [10]

    Lee YY, Annamalai C, Rao S. Post-Infectious Irritable Bowel Syndrome[J]. Curr Gastroenterol Rep, 2017, 19(11): 56. doi: 10.1007/s11894-017-0595-4

    [11]

    Chabbi-Achengli Y, Coman T, Collet C, et al. Serotonin Is Involved in Autoimmune Arthritis through Th17 Immunity and Bone Resorption[J]. Am J Pathol, 2016, 186(4): 927-937. doi: 10.1016/j.ajpath.2015.11.018

    [12]

    Long Y, Wang W, Wang H, et al. Characteristics of intestinal lamina propria dendritic cells in a mouse model of postinfectious irritable bowel syndrome[J]. J Gastroenterol Hepatol, 2012, 27(5): 935-944. doi: 10.1111/j.1440-1746.2011.07046.x

    [13]

    Matsuda M, Huh Y, Ji RR. Roles of inflammation, neurogenic inflammation, and neuroinflammation in pain[J]. J Anesth, 2019, 33(1): 131-139. doi: 10.1007/s00540-018-2579-4

    [14]

    Nozu T, Miyagishi S, Nozu R, et al. Lipopolysaccharide induces visceral hypersensitivity: role of interleukin-1, interleukin-6, and peripheral corticotropin-releasing factor in rats[J]. J Gastroenterol, 2017, 52(1): 72-80. doi: 10.1007/s00535-016-1208-y

    [15]

    Zhao Q, Yang WR, Wang XH, et al. Clostridium butyricum alleviates intestinal low-grade inflammation in TNBS-induced irritable bowel syndrome in mice by regulating functional status of lamina propria dendritic cells[J]. World J Gastroenterol, 2019, 25(36): 5469-5482. doi: 10.3748/wjg.v25.i36.5469

    [16]

    Yu YC, Li J, Zhang M, et al. Resveratrol Improves Brain-Gut Axis by Regulation of 5-HT-Dependent Signaling in the Rat Model of Irritable Bowel Syndrome[J]. Front Cell Neurosci, 2019, 13: 30.

    [17]

    Yu Y, Villalobos-Hernandez EC, Pradhananga S, et al. Deoxycholic acid activates colonic afferent nerves via 5-HT3 receptor-dependent and-independent mechanisms[J]. Am J Physiol Gastrointest Liver Physiol, 2019, 317(3): G275-G284. doi: 10.1152/ajpgi.00016.2019

    [18]

    Zhang Y, Qin G, Liu DR, et al. Increased expression of brain-derived neurotrophic factor is correlated with visceral hypersensitivity in patients with diarrhea-predominant irritable bowel syndrome[J]. World J Gastroenterol, 2019, 25(2): 269-281. doi: 10.3748/wjg.v25.i2.269

    [19]

    Sadeghi A, Biglari M, Nasseri MS. Post-infectious Irritable Bowel Syndrome: A Narrative Review[J]. Middle East J Dig Dis, 2019, 11(2): 69-75. doi: 10.15171/mejdd.2019.130

    [20]

    Fattori V, Pinho-Ribeiro FA, Staurengo-Ferrari L, et al. The specialised pro-resolving lipid mediator maresin 1 reduces inflammatory pain with a long-lasting analgesic effect[J]. Br J Pharmacol, 2019, 176(11): 1728-1744. doi: 10.1111/bph.14647

    [21]

    李安德, 崔宁, 苌华颖, 等. 急性感染性腹泻的证候分布特点[J]. 北京中医药大学学报(中医临床版), 2011, 18(5): 5-8. https://www.cnki.com.cn/Article/CJFDTOTAL-JZYL201105006.htm

    [22]

    Wouters MM, Van Wanrooy S, Nguyen A, et al. Psychological comorbidity increases the risk for postinfectious IBS partly by enhanced susceptibility to develop infectious gastroenteritis[J]. Gut, 2016, 65(8): 1279-1288. doi: 10.1136/gutjnl-2015-309460

    [23]

    杨俭勤, 唐旭东. 中医药治疗感染后肠易激综合征思路探讨[J]. 中华中医药杂志, 2010, 25(4): 560-564. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201004025.htm

    [24]

    吴皓萌, 敖海清, 徐志伟, 等. 腹泻型肠易激综合征中医证候与外周敏化关系的研究[J]. 中华中医药杂志, 2015, 30(5): 1371-1375. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201505002.htm

    [25]

    吴皓萌, 敖海清, 黄绍刚, 等. 疏肝健脾方干预腹泻型肠易激综合征内脏高敏感性大鼠的效应机制[J]. 中华中医药杂志, 2018, 33(1): 317-320. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201801085.htm

    [26]

    李晓娟. 肝郁脾虚证-逍遥散(方证)弓状核的全基因组DNA甲基化及其调控[D]. 北京: 北京中医药大学, 2018.

    [27]

    汪正芳, 贾玉, 侯亚男. 疏肝健脾法治疗腹泻型肠易激综合征肝郁脾虚证的临床观察及对血清脑肠肽水平的影响[J]. 世界中医药, 2016, 11(12): 2685-2688. https://www.cnki.com.cn/Article/CJFDTOTAL-SJZA201612042.htm

    [28]

    张北华, 王微, 王凤云, 等. 痛泻要方干预腹泻型肠易激综合征肝郁脾虚证模型大鼠的效应评价[J]. 中华中医药杂志, 2018, 33(10): 4341-4346. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201810020.htm

    [29]

    Fehervari Z. Humidity and immunity[J]. Nat Immunol, 2019, 20(7): 776.

    [30]

    Wang C, Bing A, Liu H, et al. High ambient humidity aggravates ammonia-induced respiratory mucosal inflammation by eliciting Th1/Th2 imbalance and NF-kappaB pathway activation in laying hens[J]. Poult Sci, 2022, 101(9): 102028.

    [31]

    郭鑫, 李昆, 王超, 等. 高湿环境对大鼠免疫功能的影响[J]. 中国应用生理学杂志, 2014, 30(1): 89-92. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGSL201401027.htm

    [32]

    Deng L, Xu H, Liu P, et al. Prolonged exposure to high humidity and high temperature environment can aggravate influenza virus infection through intestinal flora and Nod/RIP2/NF-kappaB signaling pathway[J]. Vet Microbiol, 2020, 251: 108896.

    [33]

    王菁. 基于"脾恶湿"探讨湿因素对大鼠各肠段免疫因子和肠道菌群的影响[D]. 北京: 北京中医药大学, 2014.

  • 加载中
计量
  • 文章访问数:  1426
  • PDF下载数:  551
  • 施引文献:  0
出版历程
收稿日期:  2022-09-30
刊出日期:  2023-01-15

目录